Literature DB >> 3878797

Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility.

D S Postma, F Gimeno, L T van der Weele, H J Sluiter.   

Abstract

The relative usefulness of various indices of (ir) reversibility in predicting survival is reported for 129 patients with severe chronic airflow limitation (initial Forced Expiratory Volume in one second, FEV1, less than or equal to 1000 ml). The generally applied increase of FEV1 as a percentage of the initial FEV1 value (delta FEV1% in) and the increase of FEV1 as a percentage of the predicted FEV1 after an anticholinergic drug (delta FEV1%pred) are not related to survival. The increase of FEV1 as a percentage of the "maximal" attainable increase to the predicted level, as estimated by predicted minus initial FEV1 (delta FEV1%(predin], is, next to the severity of airflow obstruction after bronchodilation (FEV1pb% pred), significantly related to prognosis. After controlling for smoking, delta FEV1% (pred-in) was the best indicator of reversibility in prognosis prediction. Next to smoking and delta FEV1% (pred-in) also the irreversible part of airflow obstruction FEV1%FIV1 after bronchodilation appeared to influence survival independently in this particular patient population with severe airflow obstruction.

Entities:  

Mesh:

Year:  1985        PMID: 3878797

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  8 in total

Review 1.  Airway hyperresponsiveness and COPD mortality.

Authors:  J Vestbo; E F Hansen
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 2.  Airway reactivity in cystic fibrosis.

Authors:  R S Tepper; H Eigen
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

3.  Oscillometric and spirometric bronchodilator response in preschool children with and without asthma.

Authors:  Youn Ho Shin; Sun Jung Jang; Jung Won Yoon; Hye Mi Jee; Sun Hee Choi; Hye Yung Yum; Man Yong Han
Journal:  Can Respir J       Date:  2012 Jul-Aug       Impact factor: 2.409

4.  A placebo-controlled blinded comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma.

Authors:  K C Bergmann; C P Bauer; A Overlack
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Reversible bronchial obstruction and disease-related health status in COPD.

Authors:  R A Incalzi; V Bellia; S Maggi; C Imperiale; O Capparella; R Pistelli; V Grassi
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

6.  Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.

Authors:  P L Brand; P H Quanjer; D S Postma; H A Kerstjens; G H Koëter; P N Dekhuijzen; H J Sluiter
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

Review 7.  Systematic review of the evidence relating FEV1 decline to giving up smoking.

Authors:  Peter N Lee; John S Fry
Journal:  BMC Med       Date:  2010-12-14       Impact factor: 8.775

8.  Airway wall thickness is increased in COPD patients with bronchodilator responsiveness.

Authors:  Victor Kim; Parag Desai; John D Newell; Barry J Make; George R Washko; Edwin K Silverman; James D Crapo; Surya P Bhatt; Gerard J Criner
Journal:  Respir Res       Date:  2014-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.